The observed upregulation of PGC-1α and OXPHOS post-ADT (Fig. 1E) suggests that ADT may drive prostate cancer cells toward a metabolic reliance on OXPHOS, facilitating progression toward the SCN state. Here, PPARGC1A is linked to prostate cancer.